Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Accumulated Expenses (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Accumulated Expenses for 12 consecutive years, with $706112.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 14.55% year-over-year to $706112.0, compared with a TTM value of $706112.0 through Dec 2025, down 14.55%, and an annual FY2025 reading of $1.3 million, up 9.18% over the prior year.
  • Accumulated Expenses was $706112.0 for Q4 2025 at Neuroone Medical Technologies, down from $1.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.3 million in Q3 2025 and bottomed at $41646.0 in Q1 2024.
  • Average Accumulated Expenses over 5 years is $674556.2, with a median of $664676.0 recorded in 2023.
  • The sharpest move saw Accumulated Expenses tumbled 93.02% in 2024, then soared 1947.22% in 2025.
  • Year by year, Accumulated Expenses stood at $356374.0 in 2021, then soared by 32.75% to $473085.0 in 2022, then soared by 31.74% to $623240.0 in 2023, then skyrocketed by 32.6% to $826386.0 in 2024, then fell by 14.55% to $706112.0 in 2025.
  • Business Quant data shows Accumulated Expenses for NMTC at $706112.0 in Q4 2025, $1.3 million in Q3 2025, and $958056.0 in Q2 2025.